TNF and Crohn disease: Anti-TNFα therapy has been approved to use in Crohn’s disease since 1998, including monoclonal antibodies or fragments thereof directed against TNF molecules, such as Infliximab (IFX), Adalimumab (ADA), Certolizumab pegol (Cimzia) [9,10].